NECLIFE Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Nectar Lifesciences Ltd

Watchlist Manager

Watchlist

Price: 10.51 INR -0.47% Market Closed

Market Cap: ₹2.4B

	Nectar Lifesciences Ltd BSE:532649	IN
B	Benchmark Electronics Inc XMUN:BMU	US
A	Asia Plus Group Holdings PCL SET:ASP	TH
A	Advanced Micro Devices Inc F:AMD	US
C	Cochlear Ltd F:OC5	AU
F	Fresenius SE & Co KGaA F:FRE	DE
P	Pharol SGPS SA XMUN:PTCA	PT

Profitability Summary

Nectar Lifesciences Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

100%

Sustainable 3Y Average Gross Margin

34%

Gross Margin is Increasing

24% > 100%

Negative Operating Margin

-2 936%

Negative 3Y Average Operating Margin

-554%

Declining Operating Margin

-1% > -2 936%

Negative Net Margin

-14 568%

Negative 3Y Average Net Margin

-42 671%

Declining Net Margin

-2% > -14 568%

Negative Free Cash Flow Margin

-17 956%

Strong 3Y Average Free Cash Flow Margin

44 066%

Declining Free Cash Flow Margin

7% > -17 956%

Negative ROE

-38%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-1%

Declining ROIC

0% > -4%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.